S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Boredom, loneliness plague Ukrainian youth near front line
Norway hits export record amid soaring gas prices
3rd Massive Dollar Upheaval Has Started (Ad)
Stocks end higher on Wall Street; economic worries hit oil
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
3rd Massive Dollar Upheaval Has Started (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Boredom, loneliness plague Ukrainian youth near front line
Norway hits export record amid soaring gas prices
3rd Massive Dollar Upheaval Has Started (Ad)
Stocks end higher on Wall Street; economic worries hit oil
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
3rd Massive Dollar Upheaval Has Started (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Boredom, loneliness plague Ukrainian youth near front line
Norway hits export record amid soaring gas prices
3rd Massive Dollar Upheaval Has Started (Ad)
Stocks end higher on Wall Street; economic worries hit oil
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
3rd Massive Dollar Upheaval Has Started (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Boredom, loneliness plague Ukrainian youth near front line
Norway hits export record amid soaring gas prices
3rd Massive Dollar Upheaval Has Started (Ad)
Stocks end higher on Wall Street; economic worries hit oil
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
3rd Massive Dollar Upheaval Has Started (Ad)
NASDAQ:NEOG

Neogen - NEOG Stock Forecast, Price & News

$22.28
+0.02 (+0.09%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$21.84
$22.33
50-Day Range
$21.27
$25.99
52-Week Range
$21.02
$47.80
Volume
4.04 million shs
Average Volume
935,529 shs
Market Capitalization
$2.40 billion
P/E Ratio
49.51
Dividend Yield
N/A
Price Target
$25.00

Neogen MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
12.2% Upside
$25.00 Price Target
Short Interest
Bearish
9.50% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.74mentions of Neogen in the last 14 days
Based on 8 Articles This Week
Insider Trading
Acquiring Shares
$483,435 Bought Last Quarter
Proj. Earnings Growth
6.25%
From $0.64 to $0.68 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.09 out of 5 stars

Medical Sector

766th out of 1,125 stocks

Diagnostic Substances Industry

9th out of 17 stocks

NEOG stock logo

About Neogen (NASDAQ:NEOG) Stock

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Neogen Trading Up 0.1 %

Shares of NEOG traded up $0.02 during trading hours on Monday, reaching $22.28. 4,042,979 shares of the stock traded hands, compared to its average volume of 935,529. Neogen has a 52 week low of $21.02 and a 52 week high of $47.80. The company has a market cap of $2.40 billion, a price-to-earnings ratio of 49.51 and a beta of 0.58. The stock has a fifty day simple moving average of $23.02 and a 200 day simple moving average of $28.40.

Wall Street Analyst Weigh In

Separately, Piper Sandler began coverage on Neogen in a report on Monday, July 11th. They set a "neutral" rating and a $25.00 price target for the company.

Insiders Place Their Bets

In other news, Director Ronald D. Green bought 1,500 shares of the company's stock in a transaction on Tuesday, August 2nd. The shares were purchased at an average price of $22.50 per share, with a total value of $33,750.00. Following the transaction, the director now directly owns 10,694 shares in the company, valued at $240,615. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. In other Neogen news, CEO John Edward Adent bought 17,500 shares of the stock in a transaction dated Friday, July 29th. The shares were bought at an average cost of $23.07 per share, for a total transaction of $403,725.00. Following the purchase, the chief executive officer now directly owns 58,103 shares of the company's stock, valued at approximately $1,340,436.21. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Ronald D. Green acquired 1,500 shares of the firm's stock in a transaction that occurred on Tuesday, August 2nd. The shares were bought at an average price of $22.50 per share, with a total value of $33,750.00. Following the acquisition, the director now directly owns 10,694 shares of the company's stock, valued at approximately $240,615. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 21,000 shares of company stock valued at $483,435. Corporate insiders own 0.52% of the company's stock.

Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

NEOG Stock News Headlines

Inflation Emergency to Disrupt Your Financial Future?
No doubt, we’re in an inflation emergency. It’s driving up prices more quickly than anything we’ve seen in our lifetime. And it’s barely begun. What impact will this change have on your money? How can you prepare starting right now? Watch the emergency briefing from Expert Sean Brodrick. pixel
Neogen Co. (NASDAQ:NEOG) CEO Buys $403,725.00 in Stock
Inflation Emergency to Disrupt Your Financial Future?
No doubt, we’re in an inflation emergency. It’s driving up prices more quickly than anything we’ve seen in our lifetime. And it’s barely begun. What impact will this change have on your money? How can you prepare starting right now? Watch the emergency briefing from Expert Sean Brodrick. pixel
Neogen (NASDAQ:NEOG) PT Raised to $26.00 at Piper Sandler
Why 3M Stock Popped Today - Nasdaq
Neogen: Fiscal Q4 Earnings Snapshot - Greenwich Time
Neogen Announces Record Revenues for Fiscal 2022
See More Headlines
Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

NEOG Company Calendar

Last Earnings
12/21/2021
Today
8/15/2022
Next Earnings (Estimated)
9/20/2022
Fiscal Year End
5/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:NEOG
CUSIP
64049110
Employees
1,039
Year Founded
1982

Price Target and Rating

Average Stock Price Forecast
$25.00
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$25.00
Forecasted Upside/Downside
+12.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$48.31 million
Pretax Margin
11.42%

Debt

Sales & Book Value

Annual Sales
$527.16 million
Cash Flow
$0.85 per share
Book Value
$8.23 per share

Miscellaneous

Free Float
107,277,000
Market Cap
$2.40 billion
Optionable
Optionable
Beta
0.58

Social Links















NEOG Stock - Frequently Asked Questions

Should I buy or sell Neogen stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" NEOG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NEOG, but not buy additional shares or sell existing shares.
View NEOG analyst ratings
or view top-rated stocks.

What is Neogen's stock price forecast for 2022?

1 brokers have issued twelve-month price objectives for Neogen's shares. Their NEOG share price forecasts range from $25.00 to $25.00. On average, they predict the company's stock price to reach $25.00 in the next twelve months. This suggests a possible upside of 12.2% from the stock's current price.
View analysts price targets for NEOG
or view top-rated stocks among Wall Street analysts.

How have NEOG shares performed in 2022?

Neogen's stock was trading at $45.41 at the beginning of 2022. Since then, NEOG shares have decreased by 50.9% and is now trading at $22.28.
View the best growth stocks for 2022 here
.

When is Neogen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, September 20th 2022.
View our NEOG earnings forecast
.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) announced its quarterly earnings results on Tuesday, December, 21st. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.17 by $0.07. The business earned $130.50 million during the quarter, compared to the consensus estimate of $129.06 million. Neogen had a net margin of 9.16% and a trailing twelve-month return on equity of 7.80%. Neogen's quarterly revenue was up 13.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.15 earnings per share.

When did Neogen's stock split?

Neogen's stock split on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly created shares were distributed to shareholders after the closing bell on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

What is John Adent's approval rating as Neogen's CEO?

31 employees have rated Neogen Chief Executive Officer John Adent on Glassdoor.com. John Adent has an approval rating of 56% among the company's employees. This puts John Adent in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA), NIKE (NKE), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Boeing (BA), JPMorgan Chase & Co. (JPM), W. P. Carey (WPC), Advanced Micro Devices (AMD) and Costco Wholesale (COST).

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

Who are Neogen's major shareholders?

Neogen's stock is owned by many different retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (4.13%), Riverbridge Partners LLC (2.72%), King Luther Capital Management Corp (1.58%), Northern Trust Corp (1.44%), Geneva Capital Management LLC (1.43%) and JPMorgan Chase & Co. (1.38%). Insiders that own company stock include Bruce Papesh, Douglas Edward Jones, James L Herbert, James P Tobin, Jason Warren Lilly, John Edward Adent, Ronald D Green, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm.
View institutional ownership trends
.

How do I buy shares of Neogen?

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $22.28.

How much money does Neogen make?

Neogen (NASDAQ:NEOG) has a market capitalization of $2.40 billion and generates $527.16 million in revenue each year. The company earns $48.31 million in net income (profit) each year or $0.45 on an earnings per share basis.

How many employees does Neogen have?

The company employs 1,039 workers across the globe.

When was Neogen founded?

Neogen was founded in 1982.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The official website for the company is www.neogen.com. The company can be reached via phone at (517) 372-9200, via email at ir@neogen.com, or via fax at 517-372-2006.

This page (NASDAQ:NEOG) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.